Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Liberty Latin America Class A
LILA
$1.69B
| $1.32M | ﹤0.01% |
+141,906
| New | +$1.64M |
|
2427
Akebia Therapeutics
AKBA
$266M
| $1.31M | ﹤0.01% |
237,527
-19,925
| -8% | -$156K |
|
2428
CALL
Intel
INTC
$462B
| $1.31M | ﹤0.01% |
+28,000
| New | +$1.31M |
|
2429
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $1.31M | ﹤0.01% |
38,016
-20,164
| -35% | -$757K |
|
2430
Imperial Oil
IMO
$63.6B
| $1.31M | ﹤0.01% |
+51,606
| New | +$1.57M |
|
2431
ZTO Express
ZTO
$16.3B
| $1.31M | ﹤0.01% |
+82,532
| New | +$1.33M |
|
|
CNSL
2432
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $1.3M | ﹤0.01% |
+132,129
| New | +$1.62M |
|
|
GFN
2433
DELISTED
General Finance Corporation
GFN
| $1.3M | ﹤0.01% |
128,965
-6,065
| -4% | -$78.9K |
|
2434
Global X MSCI Argentina ETF
ARGT
$832M
| $1.3M | ﹤0.01% |
55,533
| – | – |
|
2435
LendingTree
TREE
$429M
| $1.3M | ﹤0.01% |
+5,935
| New | +$1.35M |
|
|
GCAP
2436
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $1.3M | ﹤0.01% |
211,597
-84,229
| -28% | -$612K |
|
2437
Descartes Systems
DSGX
$6.64B
| $1.3M | ﹤0.01% |
+49,185
| New | +$1.44M |
|
2438
Cars.com
CARS
$661M
| $1.29M | ﹤0.01% |
60,111
-193,235
| -76% | -$4.83M |
|
2439
Community Trust Bancorp
CTBI
$1.39B
| $1.29M | ﹤0.01% |
32,600
-5,989
| -16% | -$263K |
|
2440
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.8B
| $1.29M | ﹤0.01% |
+11,299
| New | +$1.43M |
|
2441
Century Communities
CCS
$2B
| $1.29M | ﹤0.01% |
74,529
-1,312,337
| -95% | -$27.4M |
|
|
AWF
2442
AllianceBernstein Global High Income Fund
AWF
$872M
| $1.28M | ﹤0.01% |
+122,050
| New | +$1.34M |
|
|
CIC.U
2443
DELISTED
Capitol Investment Corp. IV
CIC.U
| $1.28M | ﹤0.01% |
125,000
| – | – |
|
2444
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.66B
| $1.28M | ﹤0.01% |
27,387
-22,195
| -45% | -$1.12M |
|
2445
Roku
ROKU
$23.7B
| $1.27M | ﹤0.01% |
41,606
+13,583
| +48% | +$640K |
|
|
BSTC
2446
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.27M | ﹤0.01% |
+20,989
| New | +$1.25M |
|
|
ACB
2447
Aurora Cannabis
ACB
$254M
| $1.27M | ﹤0.01% |
+2,127
| New | +$1.57M |
|
2448
Aptiv
APTV
$9.68B
| $1.27M | ﹤0.01% |
20,570
-567,993
| -97% | -$41.2M |
|
2449
DHI Group
DHX
$190M
| $1.26M | ﹤0.01% |
831,148
-647,269
| -44% | -$1.12M |
|
|
PETQ
2450
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.26M | ﹤0.01% |
53,660
-179,516
| -77% | -$5.54M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.